ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bovine Blood Plasma Derivatives Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-33N4842
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Bovine Blood Plasma Derivatives Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Bovine Blood Plasma Derivatives Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-33N4842
Report
July 2025
Pages:194
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning Inc
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac

Bovine Blood Plasma Derivatives Market Size

In 2024, the global market size of Bovine Blood Plasma Derivatives was estimated to be worth US$ 2203 million and is forecast to reach approximately US$ 3560 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

Bovine Blood Plasma Derivatives Market

Bovine Blood Plasma Derivatives Market

This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bovine Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Blood Plasma Derivatives.
The Bovine Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of sales volume (K Liters) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bovine Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bovine Blood Plasma Derivatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Bovine Blood Plasma Derivatives Market Report

Report Metric Details
Report Name Bovine Blood Plasma Derivatives Market
CAGR 7.2%
Segment by Type
  • Bovine Serum
  • FBS
  • Bovine Serum Albumin
  • Fibrinogen
  • Protein Ingredient
  • Other
Segment by Application
  • Scientific Research
  • Industrial Production
  • Feed
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, VWR, Corning, Serana, Lanzhou Minhai, Zhejiang Tianhang Biotechnology, ExCell Bio, Jin Yuan Kang, American Protein Company, Sonac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Bovine Blood Plasma Derivatives in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Bovine Blood Plasma Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bovine Blood Plasma Derivatives sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Bovine Blood Plasma Derivatives Market?

Ans: Global top three manufacturers hold a share about 30%.

What is the Bovine Blood Plasma Derivatives Market share by type?

Ans: In terms of product, FBS is the largest segment, with a share over 65%.

Who are the main players in the Bovine Blood Plasma Derivatives Market report?

Ans: The main players in the Bovine Blood Plasma Derivatives Market are Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen, Biowest, Internegocios, RMBIO, Biological Industries, VWR, Corning, Serana, Lanzhou Minhai, Zhejiang Tianhang Biotechnology, ExCell Bio, Jin Yuan Kang, American Protein Company, Sonac

What are the Application segmentation covered in the Bovine Blood Plasma Derivatives Market report?

Ans: The Applications covered in the Bovine Blood Plasma Derivatives Market report are Scientific Research, Industrial Production, Feed, Others

What are the Type segmentation covered in the Bovine Blood Plasma Derivatives Market report?

Ans: The Types covered in the Bovine Blood Plasma Derivatives Market report are Bovine Serum, FBS, Bovine Serum Albumin, Fibrinogen, Protein Ingredient, Other

1 Study Coverage
1.1 Bovine Blood Plasma Derivatives Product Introduction
1.2 Market by Type
1.2.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Bovine Serum
1.2.3 FBS
1.2.4 Bovine Serum Albumin
1.2.5 Fibrinogen
1.2.6 Protein Ingredient
1.2.7 Other
1.3 Market by Application
1.3.1 Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.3.4 Feed
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bovine Blood Plasma Derivatives Market Size Estimates and Forecasts
2.1.1 Global Bovine Blood Plasma Derivatives Revenue 2020-2031
2.1.2 Global Bovine Blood Plasma Derivatives Sales 2020-2031
2.2 Bovine Blood Plasma Derivatives Market Size by Region: 2024 Versus 2031
2.3 Bovine Blood Plasma Derivatives Sales by Region (2020-2031)
2.3.1 Global Bovine Blood Plasma Derivatives Sales by Region: 2020-2025
2.3.2 Global Bovine Blood Plasma Derivatives Sales Forecast by Region (2026-2031)
2.3.3 Global Bovine Blood Plasma Derivatives Sales Market Share by Region (2020-2031)
2.4 Bovine Blood Plasma Derivatives Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Bovine Blood Plasma Derivatives Revenue by Region: 2020-2025
2.4.2 Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2026-2031)
2.4.3 Global Bovine Blood Plasma Derivatives Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Bovine Blood Plasma Derivatives Sales by Type (2020-2031)
3.1.1.1 Global Bovine Blood Plasma Derivatives Sales Volume by Type (2020-2031)
3.1.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2031)
3.1.2 Global Bovine Blood Plasma Derivatives Revenue by Type (2020-2031)
3.1.2.1 Global Bovine Blood Plasma Derivatives Revenue by Type (2020-2031)
3.1.2.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Type (2020-2031)
3.1.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Bovine Blood Plasma Derivatives Sales by Application (2020-2031)
3.2.1.1 Global Bovine Blood Plasma Derivatives Sales Volume by Application (2020-2031)
3.2.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2031)
3.2.2 Global Bovine Blood Plasma Derivatives Revenue by Application (2020-2031)
3.2.2.1 Global Bovine Blood Plasma Derivatives Revenue by Application (2020-2031)
3.2.2.2 Global Bovine Blood Plasma Derivatives Revenue Market Share by Application (2020-2031)
3.2.3 Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Bovine Serum of Bovine Blood Plasma Derivatives Revenue Market Share by Application
3.3.2 FBS of Bovine Blood Plasma Derivatives Revenue Market Share by Application
3.3.3 Bovine Serum Albumin of Bovine Blood Plasma Derivatives Revenue Market Share by Application
3.3.4 Fibrinogen of Bovine Blood Plasma Derivatives Revenue Market Share by Application
3.3.5 Protein Ingredient of Bovine Blood Plasma Derivatives Revenue Market Share by Application
3.3.6 Other of Bovine Blood Plasma Derivatives Revenue Market Share by Application
4 Global Bovine Blood Plasma Derivatives by Manufacturers
4.1 Global Top Bovine Blood Plasma Derivatives Manufacturers by Sales (2020-2025)
4.1.1 Global Bovine Blood Plasma Derivatives Sales by Manufacturer (2020-2025)
4.1.2 Global Bovine Blood Plasma Derivatives Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue (2020-2025)
4.2.1 Global Bovine Blood Plasma Derivatives Revenue by Manufacturer (2020-2025)
4.2.2 Global Bovine Blood Plasma Derivatives Revenue Share by Manufacturer (2020-2025)
4.3 Global Bovine Blood Plasma Derivatives Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Bovine Blood Plasma Derivatives Manufacturers Covered: Ranking by Revenue
4.4.2 Global Bovine Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Bovine Blood Plasma Derivatives Manufacturing Base Distribution, Product Type
4.5.1 Bovine Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Bovine Blood Plasma Derivatives Market
4.5.3 Manufacturers Bovine Blood Plasma Derivatives Product Type and Application
4.5.4 Bovine Serum Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.5.5 FBS Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.5.6 Bovine Serum Albumin Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.5.7 Fibrinogen Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.5.8 Protein Ingredient Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.5.9 Other Market Sales of Bovine Blood Plasma Derivatives by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Company Information
5.1.2 Thermo Fisher Description, Business Overview
5.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Products Offered
5.1.4 Thermo Fisher Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Bovine Blood Plasma Derivatives Sales by Product in 2024
5.1.6 Thermo Fisher Bovine Blood Plasma Derivatives Sales by Application in 2024
5.1.7 Thermo Fisher Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.1.8 Thermo Fisher Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Company Information
5.2.2 GE Healthcare Description, Business Overview
5.2.3 GE Healthcare Bovine Blood Plasma Derivatives Products Offered
5.2.4 GE Healthcare Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GE Healthcare Bovine Blood Plasma Derivatives Sales by Product in 2024
5.2.6 GE Healthcare Bovine Blood Plasma Derivatives Sales by Application in 2024
5.2.7 GE Healthcare Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.2.8 GE Healthcare Recent Developments
5.3 Merck (Sigma-Aldrich)
5.3.1 Merck (Sigma-Aldrich) Company Information
5.3.2 Merck (Sigma-Aldrich) Description, Business Overview
5.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Products Offered
5.3.4 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales by Product in 2024
5.3.6 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales by Application in 2024
5.3.7 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.3.8 Merck (Sigma-Aldrich) Recent Developments
5.4 Moregate BioTech
5.4.1 Moregate BioTech Company Information
5.4.2 Moregate BioTech Description, Business Overview
5.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Products Offered
5.4.4 Moregate BioTech Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Moregate BioTech Bovine Blood Plasma Derivatives Sales by Product in 2024
5.4.6 Moregate BioTech Bovine Blood Plasma Derivatives Sales by Application in 2024
5.4.7 Moregate BioTech Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.4.8 Moregate BioTech Recent Developments
5.5 Gemini
5.5.1 Gemini Company Information
5.5.2 Gemini Description, Business Overview
5.5.3 Gemini Bovine Blood Plasma Derivatives Products Offered
5.5.4 Gemini Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Gemini Bovine Blood Plasma Derivatives Sales by Product in 2024
5.5.6 Gemini Bovine Blood Plasma Derivatives Sales by Application in 2024
5.5.7 Gemini Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.5.8 Gemini Recent Developments
5.6 Atlanta Biologicals
5.6.1 Atlanta Biologicals Company Information
5.6.2 Atlanta Biologicals Description, Business Overview
5.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Products Offered
5.6.4 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales by Product in 2024
5.6.6 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales by Application in 2024
5.6.7 Atlanta Biologicals Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.6.8 Atlanta Biologicals Recent Developments
5.7 Tissue Culture Biologicals
5.7.1 Tissue Culture Biologicals Company Information
5.7.2 Tissue Culture Biologicals Description, Business Overview
5.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Products Offered
5.7.4 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales by Product in 2024
5.7.6 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales by Application in 2024
5.7.7 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.7.8 Tissue Culture Biologicals Recent Developments
5.8 Bovogen
5.8.1 Bovogen Company Information
5.8.2 Bovogen Description, Business Overview
5.8.3 Bovogen Bovine Blood Plasma Derivatives Products Offered
5.8.4 Bovogen Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Bovogen Bovine Blood Plasma Derivatives Sales by Product in 2024
5.8.6 Bovogen Bovine Blood Plasma Derivatives Sales by Application in 2024
5.8.7 Bovogen Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.8.8 Bovogen Recent Developments
5.9 Biowest
5.9.1 Biowest Company Information
5.9.2 Biowest Description, Business Overview
5.9.3 Biowest Bovine Blood Plasma Derivatives Products Offered
5.9.4 Biowest Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Biowest Bovine Blood Plasma Derivatives Sales by Product in 2024
5.9.6 Biowest Bovine Blood Plasma Derivatives Sales by Application in 2024
5.9.7 Biowest Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.9.8 Biowest Recent Developments
5.10 Internegocios
5.10.1 Internegocios Company Information
5.10.2 Internegocios Description, Business Overview
5.10.3 Internegocios Bovine Blood Plasma Derivatives Products Offered
5.10.4 Internegocios Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Internegocios Bovine Blood Plasma Derivatives Sales by Product in 2024
5.10.6 Internegocios Bovine Blood Plasma Derivatives Sales by Application in 2024
5.10.7 Internegocios Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.10.8 Internegocios Recent Developments
5.11 RMBIO
5.11.1 RMBIO Company Information
5.11.2 RMBIO Description, Business Overview
5.11.3 RMBIO Bovine Blood Plasma Derivatives Products Offered
5.11.4 RMBIO Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.11.5 RMBIO Bovine Blood Plasma Derivatives Sales by Product in 2024
5.11.6 RMBIO Bovine Blood Plasma Derivatives Sales by Application in 2024
5.11.7 RMBIO Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.11.8 RMBIO Recent Developments
5.12 Biological Industries
5.12.1 Biological Industries Company Information
5.12.2 Biological Industries Description, Business Overview
5.12.3 Biological Industries Bovine Blood Plasma Derivatives Products Offered
5.12.4 Biological Industries Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Biological Industries Bovine Blood Plasma Derivatives Sales by Product in 2024
5.12.6 Biological Industries Bovine Blood Plasma Derivatives Sales by Application in 2024
5.12.7 Biological Industries Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.12.8 Biological Industries Recent Developments
5.13 VWR
5.13.1 VWR Company Information
5.13.2 VWR Description, Business Overview
5.13.3 VWR Bovine Blood Plasma Derivatives Products Offered
5.13.4 VWR Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.13.5 VWR Bovine Blood Plasma Derivatives Sales by Product in 2024
5.13.6 VWR Bovine Blood Plasma Derivatives Sales by Application in 2024
5.13.7 VWR Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.13.8 VWR Recent Developments
5.14 Corning
5.14.1 Corning Company Information
5.14.2 Corning Description, Business Overview
5.14.3 Corning Bovine Blood Plasma Derivatives Products Offered
5.14.4 Corning Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Corning Bovine Blood Plasma Derivatives Sales by Product in 2024
5.14.6 Corning Bovine Blood Plasma Derivatives Sales by Application in 2024
5.14.7 Corning Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.14.8 Corning Recent Developments
5.15 Serana
5.15.1 Serana Company Information
5.15.2 Serana Description, Business Overview
5.15.3 Serana Bovine Blood Plasma Derivatives Products Offered
5.15.4 Serana Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Serana Bovine Blood Plasma Derivatives Sales by Product in 2024
5.15.6 Serana Bovine Blood Plasma Derivatives Sales by Application in 2024
5.15.7 Serana Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.15.8 Serana Recent Developments
5.16 Lanzhou Minhai
5.16.1 Lanzhou Minhai Company Information
5.16.2 Lanzhou Minhai Description, Business Overview
5.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Products Offered
5.16.4 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales by Product in 2024
5.16.6 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales by Application in 2024
5.16.7 Lanzhou Minhai Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.16.8 Lanzhou Minhai Recent Developments
5.17 Zhejiang Tianhang Biotechnology
5.17.1 Zhejiang Tianhang Biotechnology Company Information
5.17.2 Zhejiang Tianhang Biotechnology Description, Business Overview
5.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Products Offered
5.17.4 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales by Product in 2024
5.17.6 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales by Application in 2024
5.17.7 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.17.8 Zhejiang Tianhang Biotechnology Recent Developments
5.18 ExCell Bio
5.18.1 ExCell Bio Company Information
5.18.2 ExCell Bio Description, Business Overview
5.18.3 ExCell Bio Bovine Blood Plasma Derivatives Products Offered
5.18.4 ExCell Bio Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.18.5 ExCell Bio Bovine Blood Plasma Derivatives Sales by Product in 2024
5.18.6 ExCell Bio Bovine Blood Plasma Derivatives Sales by Application in 2024
5.18.7 ExCell Bio Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.18.8 ExCell Bio Recent Developments
5.19 Jin Yuan Kang
5.19.1 Jin Yuan Kang Company Information
5.19.2 Jin Yuan Kang Description, Business Overview
5.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Products Offered
5.19.4 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales by Product in 2024
5.19.6 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales by Application in 2024
5.19.7 Jin Yuan Kang Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.19.8 Jin Yuan Kang Recent Developments
5.20 American Protein Company
5.20.1 American Protein Company Company Information
5.20.2 American Protein Company Description, Business Overview
5.20.3 American Protein Company Bovine Blood Plasma Derivatives Products Offered
5.20.4 American Protein Company Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.20.5 American Protein Company Bovine Blood Plasma Derivatives Sales by Product in 2024
5.20.6 American Protein Company Bovine Blood Plasma Derivatives Sales by Application in 2024
5.20.7 American Protein Company Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.20.8 American Protein Company Recent Developments
5.21 Sonac
5.21.1 Sonac Company Information
5.21.2 Sonac Description, Business Overview
5.21.3 Sonac Bovine Blood Plasma Derivatives Products Offered
5.21.4 Sonac Bovine Blood Plasma Derivatives Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Sonac Bovine Blood Plasma Derivatives Sales by Product in 2024
5.21.6 Sonac Bovine Blood Plasma Derivatives Sales by Application in 2024
5.21.7 Sonac Bovine Blood Plasma Derivatives Sales by Geographic Area in 2024
5.21.8 Sonac Recent Developments
6 North America
6.1 North America Bovine Blood Plasma Derivatives Market Size YoY Growth 2020-2031
6.2 North America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
6.2.1 North America Bovine Blood Plasma Derivatives Sales by Country (2020-2031)
6.2.2 North America Bovine Blood Plasma Derivatives Revenue by Country (2020-2031)
6.3 North America Bovine Blood Plasma Derivatives Sales by Type (2020-2025)
6.4 North America Bovine Blood Plasma Derivatives Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Bovine Blood Plasma Derivatives Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Bovine Blood Plasma Derivatives Market Facts & Figures by Region
7.2.1 Asia-Pacific Bovine Blood Plasma Derivatives Sales by Region (2020-2031)
7.2.2 Asia-Pacific Bovine Blood Plasma Derivatives Revenue by Region (2020-2031)
7.3 Asia-Pacific Bovine Blood Plasma Derivatives Sales by Type (2020-2025)
7.4 Asia-Pacific Bovine Blood Plasma Derivatives Sales by Application (2020-2025)
8 Europe
8.1 Europe Bovine Blood Plasma Derivatives Market Size YoY Growth 2020-2031
8.2 Europe Bovine Blood Plasma Derivatives Market Facts & Figures by Country
8.2.1 Europe Bovine Blood Plasma Derivatives Sales by Country (2020-2031)
8.2.2 Europe Bovine Blood Plasma Derivatives Revenue by Country (2020-2031)
8.3 Europe Bovine Blood Plasma Derivatives Sales by Type (2020-2025)
8.4 Europe Bovine Blood Plasma Derivatives Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Bovine Blood Plasma Derivatives Market Size YoY Growth 2020-2031
9.2 Latin America Bovine Blood Plasma Derivatives Market Facts & Figures by Country
9.2.1 Latin America Bovine Blood Plasma Derivatives Sales by Country (2020-2031)
9.2.2 Latin America Bovine Blood Plasma Derivatives Revenue by Country (2020-2031)
9.3 Latin America Bovine Blood Plasma Derivatives Sales by Type (2020-2025)
9.4 Latin America Bovine Blood Plasma Derivatives Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Bovine Blood Plasma Derivatives Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Bovine Blood Plasma Derivatives Market Facts & Figures by Country
10.2.1 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2020-2031)
10.2.2 Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2020-2031)
10.3 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2020-2025)
10.4 Middle East and Africa Bovine Blood Plasma Derivatives Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Bovine Blood Plasma Derivatives Supply Chain Analysis
11.2 Bovine Blood Plasma Derivatives Key Raw Materials and Upstream Suppliers
11.3 Bovine Blood Plasma Derivatives Clients Analysis
11.4 Bovine Blood Plasma Derivatives Sales Channel and Sales Model Analysis
11.4.1 Bovine Blood Plasma Derivatives Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Bovine Blood Plasma Derivatives Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Bovine Blood Plasma Derivatives Distributors
12 Bovine Blood Plasma Derivatives Market Dynamics
12.1 Bovine Blood Plasma Derivatives Industry Trends
12.2 Bovine Blood Plasma Derivatives Market Drivers
12.3 Bovine Blood Plasma Derivatives Market Challenges
12.4 Bovine Blood Plasma Derivatives Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning Inc
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
List of Tables
 Table 1. Global Bovine Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Bovine Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Bovine Blood Plasma Derivatives Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Bovine Blood Plasma Derivatives Sales by Region (2020-2025) & (K Liters)
 Table 5. Global Bovine Blood Plasma Derivatives Sales Forecast by Region (2026-2031) & (K Liters)
 Table 6. Global Bovine Blood Plasma Derivatives Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Bovine Blood Plasma Derivatives Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Bovine Blood Plasma Derivatives Sales Volume by Type (2020-2025) & (K Liters)
 Table 9. Global Bovine Blood Plasma Derivatives Sales Volume by Type (2026-2031) & (K Liters)
 Table 10. Global Bovine Blood Plasma Derivatives Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Bovine Blood Plasma Derivatives Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Bovine Blood Plasma Derivatives Sales Volume by Application (2020-2025) & (K Liters)
 Table 13. Global Bovine Blood Plasma Derivatives Sales Volume by Application (2026-2031) & (K Liters)
 Table 14. Global Bovine Blood Plasma Derivatives Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Bovine Blood Plasma Derivatives Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Bovine Blood Plasma Derivatives Sales by Manufacturer (2020-2025) & (K Liters)
 Table 17. Global Bovine Blood Plasma Derivatives Sales Share by Manufacturer (2020-2025)
 Table 18. Bovine Blood Plasma Derivatives Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Bovine Blood Plasma Derivatives Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Bovine Blood Plasma Derivatives Price (2020-2025) & (USD/L)
 Table 21. Ranking of Global Top Bovine Blood Plasma Derivatives Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Bovine Blood Plasma Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Bovine Blood Plasma Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Blood Plasma Derivatives as of 2024)
 Table 24. Bovine Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Bovine Blood Plasma Derivatives Market
 Table 26. Manufacturers Bovine Blood Plasma Derivatives Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Thermo Fisher Company Information
 Table 29. Thermo Fisher Description and Business Overview
 Table 30. Thermo Fisher Bovine Blood Plasma Derivatives Product
 Table 31. Thermo Fisher Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 32. Thermo Fisher Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 33. Thermo Fisher Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 34. Thermo Fisher Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 35. Thermo Fisher Recent Developments
 Table 36. GE Healthcare Company Information
 Table 37. GE Healthcare Description and Business Overview
 Table 38. GE Healthcare Bovine Blood Plasma Derivatives Product
 Table 39. GE Healthcare Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 40. GE Healthcare Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 41. GE Healthcare Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 42. GE Healthcare Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 43. GE Healthcare Recent Developments
 Table 44. Merck (Sigma-Aldrich) Company Information
 Table 45. Merck (Sigma-Aldrich) Description and Business Overview
 Table 46. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product
 Table 47. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 48. Merck (Sigma-Aldrich) Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 49. Merck (Sigma-Aldrich) Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 50. Merck (Sigma-Aldrich) Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 51. Merck (Sigma-Aldrich) Recent Developments
 Table 52. Moregate BioTech Company Information
 Table 53. Moregate BioTech Description and Business Overview
 Table 54. Moregate BioTech Bovine Blood Plasma Derivatives Product
 Table 55. Moregate BioTech Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 56. Moregate BioTech Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 57. Moregate BioTech Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 58. Moregate BioTech Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 59. Moregate BioTech Recent Developments
 Table 60. Gemini Company Information
 Table 61. Gemini Description and Business Overview
 Table 62. Gemini Bovine Blood Plasma Derivatives Product
 Table 63. Gemini Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 64. Gemini Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 65. Gemini Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 66. Gemini Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 67. Gemini Recent Developments
 Table 68. Atlanta Biologicals Company Information
 Table 69. Atlanta Biologicals Description and Business Overview
 Table 70. Atlanta Biologicals Bovine Blood Plasma Derivatives Product
 Table 71. Atlanta Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 72. Atlanta Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 73. Atlanta Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 74. Atlanta Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 75. Atlanta Biologicals Recent Developments
 Table 76. Tissue Culture Biologicals Company Information
 Table 77. Tissue Culture Biologicals Description and Business Overview
 Table 78. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product
 Table 79. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 80. Tissue Culture Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 81. Tissue Culture Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 82. Tissue Culture Biologicals Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 83. Tissue Culture Biologicals Recent Developments
 Table 84. Bovogen Company Information
 Table 85. Bovogen Description and Business Overview
 Table 86. Bovogen Bovine Blood Plasma Derivatives Product
 Table 87. Bovogen Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 88. Bovogen Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 89. Bovogen Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 90. Bovogen Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 91. Bovogen Recent Developments
 Table 92. Biowest Company Information
 Table 93. Biowest Description and Business Overview
 Table 94. Biowest Bovine Blood Plasma Derivatives Product
 Table 95. Biowest Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 96. Biowest Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 97. Biowest Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 98. Biowest Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 99. Biowest Recent Developments
 Table 100. Internegocios Company Information
 Table 101. Internegocios Description and Business Overview
 Table 102. Internegocios Bovine Blood Plasma Derivatives Product
 Table 103. Internegocios Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 104. Internegocios Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 105. Internegocios Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 106. Internegocios Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 107. Internegocios Recent Developments
 Table 108. RMBIO Company Information
 Table 109. RMBIO Description and Business Overview
 Table 110. RMBIO Bovine Blood Plasma Derivatives Product
 Table 111. RMBIO Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 112. RMBIO Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 113. RMBIO Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 114. RMBIO Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 115. RMBIO Recent Developments
 Table 116. Biological Industries Company Information
 Table 117. Biological Industries Description and Business Overview
 Table 118. Biological Industries Bovine Blood Plasma Derivatives Product
 Table 119. Biological Industries Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 120. Biological Industries Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 121. Biological Industries Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 122. Biological Industries Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 123. Biological Industries Recent Developments
 Table 124. VWR Company Information
 Table 125. VWR Description and Business Overview
 Table 126. VWR Bovine Blood Plasma Derivatives Product
 Table 127. VWR Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 128. VWR Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 129. VWR Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 130. VWR Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 131. VWR Recent Developments
 Table 132. Corning Company Information
 Table 133. Corning Description and Business Overview
 Table 134. Corning Bovine Blood Plasma Derivatives Product
 Table 135. Corning Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 136. Corning Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 137. Corning Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 138. Corning Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 139. Corning Recent Developments
 Table 140. Serana Company Information
 Table 141. Serana Description and Business Overview
 Table 142. Serana Bovine Blood Plasma Derivatives Product
 Table 143. Serana Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 144. Serana Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 145. Serana Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 146. Serana Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 147. Serana Recent Developments
 Table 148. Lanzhou Minhai Company Information
 Table 149. Lanzhou Minhai Description and Business Overview
 Table 150. Lanzhou Minhai Bovine Blood Plasma Derivatives Product
 Table 151. Lanzhou Minhai Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 152. Lanzhou Minhai Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 153. Lanzhou Minhai Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 154. Lanzhou Minhai Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 155. Lanzhou Minhai Recent Developments
 Table 156. Zhejiang Tianhang Biotechnology Company Information
 Table 157. Zhejiang Tianhang Biotechnology Description and Business Overview
 Table 158. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product
 Table 159. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 160. Zhejiang Tianhang Biotechnology Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 161. Zhejiang Tianhang Biotechnology Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 162. Zhejiang Tianhang Biotechnology Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 163. Zhejiang Tianhang Biotechnology Recent Developments
 Table 164. ExCell Bio Company Information
 Table 165. ExCell Bio Description and Business Overview
 Table 166. ExCell Bio Bovine Blood Plasma Derivatives Product
 Table 167. ExCell Bio Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 168. ExCell Bio Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 169. ExCell Bio Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 170. ExCell Bio Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 171. ExCell Bio Recent Developments
 Table 172. Jin Yuan Kang Company Information
 Table 173. Jin Yuan Kang Description and Business Overview
 Table 174. Jin Yuan Kang Bovine Blood Plasma Derivatives Product
 Table 175. Jin Yuan Kang Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 176. Jin Yuan Kang Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 177. Jin Yuan Kang Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 178. Jin Yuan Kang Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 179. Jin Yuan Kang Recent Developments
 Table 180. American Protein Company Company Information
 Table 181. American Protein Company Description and Business Overview
 Table 182. American Protein Company Bovine Blood Plasma Derivatives Product
 Table 183. American Protein Company Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 184. American Protein Company Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 185. American Protein Company Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 186. American Protein Company Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 187. American Protein Company Recent Developments
 Table 188. Sonac Company Information
 Table 189. Sonac Description and Business Overview
 Table 190. Sonac Bovine Blood Plasma Derivatives Product
 Table 191. Sonac Bovine Blood Plasma Derivatives Sales (K Liters), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 192. Sonac Sales Proportion of Bovine Blood Plasma Derivatives by Product in 2024
 Table 193. Sonac Sales Proportion of Bovine Blood Plasma Derivatives by Application in 2024
 Table 194. Sonac Sales Proportion of Bovine Blood Plasma Derivatives by Geographic Area in 2024
 Table 195. Sonac Recent Developments
 Table 196. North America Bovine Blood Plasma Derivatives Sales by Country (2020-2025) & (K Liters)
 Table 197. North America Bovine Blood Plasma Derivatives Sales by Country (2026-2031) & (K Liters)
 Table 198. North America Bovine Blood Plasma Derivatives Revenue by Country (2020-2025) & (US$ Million)
 Table 199. North America Bovine Blood Plasma Derivatives Revenue by Country (2026-2031) & (US$ Million)
 Table 200. North America Bovine Blood Plasma Derivatives Sales by Type (2020-2025) & (K Liters)
 Table 201. North America Bovine Blood Plasma Derivatives Sales by Application (2020-2025) & (K Liters)
 Table 202. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Region (2020-2025) & (K Liters)
 Table 203. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Region (2026-2031) & (K Liters)
 Table 204. Asia-Pacific Bovine Blood Plasma Derivatives Revenue by Region (2020-2025) & (US$ Million)
 Table 205. Asia-Pacific Bovine Blood Plasma Derivatives Revenue by Region (2026-2031) & (US$ Million)
 Table 206. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Type (2020-2025) & (K Liters)
 Table 207. Asia-Pacific Bovine Blood Plasma Derivatives Sales by Application (2020-2025) & (K Liters)
 Table 208. Europe Bovine Blood Plasma Derivatives Sales by Country (2020-2025) & (K Liters)
 Table 209. Europe Bovine Blood Plasma Derivatives Sales by Country (2026-2031) & (K Liters)
 Table 210. Europe Bovine Blood Plasma Derivatives Revenue by Country (2020-2025) & (US$ Million)
 Table 211. Europe Bovine Blood Plasma Derivatives Revenue by Country (2026-2031) & (US$ Million)
 Table 212. Europe Bovine Blood Plasma Derivatives Sales by Type (2020-2025) & (K Liters)
 Table 213. Europe Bovine Blood Plasma Derivatives Sales by Application (2020-2025) & (K Liters)
 Table 214. Latin America Bovine Blood Plasma Derivatives Sales by Country (2020-2025) & (K Liters)
 Table 215. Latin America Bovine Blood Plasma Derivatives Sales by Country (2026-2031) & (K Liters)
 Table 216. Latin America Bovine Blood Plasma Derivatives Revenue by Country (2020-2025) & (US$ Million)
 Table 217. Latin America Bovine Blood Plasma Derivatives Revenue by Country (2026-2031) & (US$ Million)
 Table 218. Latin America Bovine Blood Plasma Derivatives Sales by Type (2020-2025) & (K Liters)
 Table 219. Latin America Bovine Blood Plasma Derivatives Sales by Application (2020-2025) & (K Liters)
 Table 220. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2020-2025) & (K Liters)
 Table 221. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Country (2026-2031) & (K Liters)
 Table 222. Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2020-2025) & (US$ Million)
 Table 223. Middle East and Africa Bovine Blood Plasma Derivatives Revenue by Country (2026-2031) & (US$ Million)
 Table 224. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Type (2020-2025) & (K Liters)
 Table 225. Middle East and Africa Bovine Blood Plasma Derivatives Sales by Application (2020-2025) & (K Liters)
 Table 226. Bovine Blood Plasma Derivatives Key Raw Materials, Industry Status and Trend
 Table 227. Bovine Blood Plasma Derivatives Key Raw Materials and Upstream Suppliers
 Table 228. Bovine Blood Plasma Derivatives Clients Status and Trend
 Table 229. Bovine Blood Plasma Derivatives Typical Clients
 Table 230. Bovine Blood Plasma Derivatives Distributors
 Table 231. Bovine Blood Plasma Derivatives Market Trends
 Table 232. Bovine Blood Plasma Derivatives Market Drivers
 Table 233. Bovine Blood Plasma Derivatives Market Challenges
 Table 234. Bovine Blood Plasma Derivatives Market Restraints
 Table 235. Research Programs/Design for This Report
 Table 236. Key Data Information from Secondary Sources
 Table 237. Key Data Information from Primary Sources
 Table 238. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Bovine Blood Plasma Derivatives Product Picture
 Figure 2. Global Bovine Blood Plasma Derivatives Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Bovine Blood Plasma Derivatives Sales Market Share by Type in 2024 & 2031
 Figure 4. Bovine Serum Product Picture
 Figure 5. FBS Product Picture
 Figure 6. Bovine Serum Albumin Product Picture
 Figure 7. Fibrinogen Product Picture
 Figure 8. Protein Ingredient Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Bovine Blood Plasma Derivatives Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 11. Global Bovine Blood Plasma Derivatives Sales Market Share by Application in 2024 & 2031
 Figure 12. Scientific Research
 Figure 13. Industrial Production
 Figure 14. Feed
 Figure 15. Others
 Figure 16. Bovine Blood Plasma Derivatives Report Years Considered
 Figure 17. Global Bovine Blood Plasma Derivatives Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Bovine Blood Plasma Derivatives Market Size 2020-2031 (US$ Million)
 Figure 19. Global Bovine Blood Plasma Derivatives Sales 2020-2031 (K Liters)
 Figure 20. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Region (2020-2031)
 Figure 21. Global Bovine Blood Plasma Derivatives Revenue Market Share by Region (2020-2031)
 Figure 22. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Type (2020-2031)
 Figure 23. Global Bovine Blood Plasma Derivatives Revenue Market Share Forecast by Type (2020-2031)
 Figure 24. Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Type (2020-2025) & (USD/L)
 Figure 25. Global Bovine Blood Plasma Derivatives Sales Market Share Forecast by Application (2020-2031)
 Figure 26. Global Bovine Blood Plasma Derivatives Revenue Market Share Forecast by Application (2020-2031)
 Figure 27. Bovine Blood Plasma Derivatives Average Selling Price (ASP) by Application (2020-2025) & (USD/L)
 Figure 28. Bovine Serum of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 29. FBS of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Bovine Serum Albumin of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 31. Fibrinogen of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 32. Protein Ingredient of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 33. Other of Bovine Blood Plasma Derivatives Revenue Market Share by Application, 2024 VS 2031
 Figure 34. Global Bovine Blood Plasma Derivatives Sales Share by Manufacturer in 2024
 Figure 35. Bovine Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Bovine Serum Market Sales Proportion by Manufacturer in 2024
 Figure 37. FBS Market Sales Proportion by Manufacturer in 2024
 Figure 38. Bovine Serum Albumin Market Sales Proportion by Manufacturer in 2024
 Figure 39. Fibrinogen Market Sales Proportion by Manufacturer in 2024
 Figure 40. Protein Ingredient Market Sales Proportion by Manufacturer in 2024
 Figure 41. Other Market Sales Proportion by Manufacturer in 2024
 Figure 42. North America Bovine Blood Plasma Derivatives Revenue 2020-2031 (US$ Million)
 Figure 43. North America Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2025)
 Figure 44. North America Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2025)
 Figure 45. Asia-Pacific Bovine Blood Plasma Derivatives Revenue 2020-2031 (US$ Million)
 Figure 46. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share by Region (2020-2031)
 Figure 47. Asia-Pacific Bovine Blood Plasma Derivatives Revenue Market Share by Region (2020-2031)
 Figure 48. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2025)
 Figure 49. Asia-Pacific Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2025)
 Figure 50. Europe Bovine Blood Plasma Derivatives Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Europe Bovine Blood Plasma Derivatives Sales Market Share by Country (2020-2031)
 Figure 52. Europe Bovine Blood Plasma Derivatives Revenue Market Share by Country (2020-2031)
 Figure 53. Europe Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2025)
 Figure 54. Europe Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2025)
 Figure 55. Latin America Bovine Blood Plasma Derivatives Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 56. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Country (2020-2031)
 Figure 57. Latin America Bovine Blood Plasma Derivatives Revenue Market Share by Country (2020-2025)
 Figure 58. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2025)
 Figure 59. Latin America Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2025)
 Figure 60. Middle East and Africa Bovine Blood Plasma Derivatives Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 61. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Country (2020-2031)
 Figure 62. Middle East and Africa Bovine Blood Plasma Derivatives Revenue Market Share by Country (2020-2031)
 Figure 63. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Type (2020-2025)
 Figure 64. Middle East and Africa Bovine Blood Plasma Derivatives Sales Market Share by Application (2020-2025)
 Figure 65. Bovine Blood Plasma Derivatives Supply Chain (Upstream and Downstream Market)
 Figure 66. Global Production Market Share of Bovine Blood Plasma Derivatives Raw Materials by Region in 2024
 Figure 67. Bovine Blood Plasma Derivatives Distribution Channels
 Figure 68. Global Bovine Blood Plasma Derivatives Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 69. Global Bovine Blood Plasma Derivatives Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Animal Blood Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Derivative Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bovine Blood Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood Product Market Insights Forecast to 2030
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Single Blood Drop Analysis Market Insights Forecast to 2030
Global Recombinant Plasma Proteins Market Insights Forecast to 2030
Global Recombinant Plasma Protein Therapeutics Market Insights Forecast to 2030
Animal Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Syngas and Derivatives Market Research Report 2024
Global Warfarin Market Insights Forecast to 2030
Global Blood and Blood Components Market Insights Forecast to 2030
Global Blood Plasma Extractor Market Insights Forecast to 2030
Global Deep Vein Thrombosis DVT Therapy Market Insights Forecast to 2030
Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Blood Plasma Fractionation Market Research Report 2025
Global Plasma derived Medical Product Market Research Report 2025
Global Plasmapheresis Systems Market Research Report 2025
Global Porcine Heparin Market Insights Forecast to 2030
Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions